| Metastatic bone disease: Pathogenesis and therapeutic options Up-date on bone metastasis management |
36 |
| Advances in immune checkpoint inhibitors for bone sarcoma therapy |
25 |
| Advances in limb salvage treatment of osteosarcoma |
21 |
| Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) |
20 |
| Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway |
15 |
| Role of autophagy in osteosarcoma |
14 |
| Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study |
13 |
| The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo |
13 |
| The role of CXCR4 in multiple myeloma: Cells' journey from bone marrow to beyond |
11 |
| Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data |
10 |
| Blockade of CCL2 enhances immunotherapeutic effect of anti-PDl in lung cancer |
10 |
| Osteoblast suppression in multiple myeloma bone disease |
10 |
| Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases |
8 |
| Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis |
8 |
| Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma |
7 |
| A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe |
7 |
| Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models |
7 |
| A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma |
6 |
| Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer |
6 |
| Prognostic nomograms for predicting overall and cancer-specific survival of high-grade osteosarcoma patients |
6 |
| Bone tumours of the clavicle: Histopathological, anatomical and epidemiological analysis of 113 cases |
5 |
| Prognostic factors for patients with chondrosarcoma: A survival analysis based on the Surveillance, Epidemiology, and End Results (SEER) database (1973-2012) |
5 |
| Retrospective investigation of paint brush borders sign in association with local recurrence of giant cell tumor of bone after intralesional curettage |
5 |
| Managements of giant cell tumor within the distal radius: A retrospective study of 58 cases from a single center |
5 |
| Surgical options and reconstruction strategies for primary bone tumors of distal tibia: A systematic review of complications and functional outcome |
5 |
| Application of 3D-printed PEEK scapula prosthesis in the treatment of scapular benign fibrous histiocytoma: A case report |
5 |
| Extracellular vesicles-mediated signaling in the osteosarcoma microenvironment: Roles and potential therapeutic targets |
5 |
| Outcomes and prognostic factors for surgically treated patients with breast cancer spine metastases |
5 |
| Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma |
5 |
| Small animal models for the study of bone sarcoma pathogenesis: characteristics, therapeutic interests and limitations |
4 |
| Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst |
4 |
| Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries |
4 |
| Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway |
4 |
| A nomogram to predict prognosis in Ewing sarcoma of bone |
4 |
| CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338 |
4 |
| MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2 |
4 |
| Atypical femoral fractures from bisphosphonate in cancer patients - Review |
4 |
| Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data |
4 |
| beta 2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1 beta and selectin-dependent manner |
4 |
| NPNT promotes early-stage bone metastases in breast cancer by regulation of the osteogenic niche |
4 |
| Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma |
3 |
| Chondrosarcoma transformation in hereditary multiple exostoses: A systematic review and clinical and cost-effectiveness of a proposed screening model |
3 |
| Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs |
3 |
| The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis |
3 |
| Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials |
3 |
| Incidence of fractures in young women with breast cancer - a retrospective cohort study |
3 |
| Aneurysmal bone cyst: A review of 65 patients |
3 |
| Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation |
3 |
| Changing landscape of optical imaging in skeletal metastases |
3 |
| Chondroblastoma in pelvis and extremities- a signle centre study of 177 cases |
3 |
